Omega- 3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder With (OMNeADHD) A Double Blind Randomized Controlled Trial of High Dose Omega- 3 Fatty Acids in Children and Adolescents With ADHD With Omega- 3 Deficiency.
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 18
Healthy Volunteers: f
View:
• DSM-5 diagnosis of ADHD
• Did not have any changes of ADHD treatment (pharmacological/psychological) within 4 weeks of entering the trial.
• SNAP-IV inattention subscale \>=12, or hyperactivity subscale \>=12, or inattention+ hyperactivity subscales \>=24
Locations
Other Locations
Taiwan
China Medical University Hospital
RECRUITING
Taichung
Contact Information
Primary
Pei-Chen Chang, PhD
013121@tool.caaumed.org.tw
+88622052121
Time Frame
Start Date: 2021-09-04
Estimated Completion Date: 2026-07-31
Participants
Target number of participants: 100
Treatments
Active_comparator: omega-3 fatty acids: EPA
EPA
Active_comparator: omega-3 fatty acids: DHA
DHA
Placebo_comparator: placebo
olive oil
Related Therapeutic Areas
Sponsors
Leads: China Medical University Hospital